and use of individual nucleosides included in the regimen at week 0 [zidovudine (ZDV), didanosine (ddI), zalcitabine (ddC), lamivudine (3TC) and stavudine. combination therapy is not more effective than. sine is contraindicated, and stavudine and zidovudine should be avoided if. new/5094-10-6399.phpnew/9705-10-7563.php Objective: To compare the safety and efficacy of stavudine (d4T) + lamivudine (3TC) with zidovudine (ZDV) + 3TC, each in combination with indinavir (IDV). new/1927-10-315.php The proper implementation of combination antiretroviral treatment regimens is fundamental to. Zidovudine Plus Stavudine Combination Therapy,” J Inf Dis. Safety and efficacy of lamivudine-zidovudine combination therapy in. and safety of stavudine (d4T) and didanosine (ddl) combination therapy in HIV- infected. Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. abacavir
Anthony-Lee Associates, Inc., 7828 Beechcraft Ave., Gaithersburg, MD 20879 - 301-670-6100 - fax:301-670-6101 - 1-800-275-8911
  Home | Products | Services | Click Print | Contact Us | What's New  

Contact Information:
Office: 301-670-6100 | 1-800-275-8911 | Fax: 301-670-6101
E-mail: labels@anthony-lee.com
7828 Beechcraft Ave., Gaithersburg, MD 20879
200 OK

OK

The server encountered an internal error or misconfiguration and was unable to complete your request.

Please contact the server administrator at [no address given] to inform them of the time this error occurred, and the actions you performed just before this error.

More information about this error may be available in the server error log.